The Claim
Remission of Graves' disease following anti-thyroid drug therapy typically requires a minimum of 18 months of treatment, and recurrence occurs frequently in the absence of sustained remission.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Patients with Graves' disease who stop anti-thyroid drugs before 18 months of treatment are more likely to experience a return of the disease. Sustained remission is uncommon without at least 18 months of continuous therapy.
See the scientific wording
Remission of Graves' disease after anti-thyroid drug therapy typically requires at least 18 months of treatment, and recurrence is common without sustained remission.
Taking thyroid-blocking medicine for at least 18 months stops the immune system from making antibodies that attack the thyroid. Over time, this allows the immune system to forget the thyroid is a threat, so it stops attacking even after the medicine is stopped. If the medicine is stopped too soon, the immune system keeps making those antibodies and the thyroid gets damaged again.
What the research says
2 studiesThis study found that many people with Graves' disease get sick again after stopping their medicine, often within a couple of years — which means taking the medicine for a long time (like 18 months or more) helps keep them healthy longer.
This study found that most people with Graves' disease get sick again after stopping medication, especially if they didn't take the drugs for a long time. That means doctors are right to say you need to take the medicine for at least 18 months to have a better chance of staying healthy.
Related videos
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 2 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.
